SCHEMBL2389562

SCHEMBL2389562

CC1(OC(=O)C2(C)CCC3OC3C2)CCC2OC2C1

nearest known ligand 0.32

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SCN1A P35498 1/20 0.32
SCN2A Q99250 1/20 0.32
SCN3A Q9NY46 1/20 0.32
MAPK1 P28482 2/20 0.31
TP53 P04637 1/20 0.31
NFKB1 P19838 1/20 0.31
CYP2C19 P33261 1/20 0.31
THPO P40225 1/20 0.31
STAT6 P42226 1/20 0.31
HIF1A Q16665 1/20 0.31
NPC1 O15118 1/20 0.31
GMNN O75496 1/20 0.31
LMNA P02545 1/20 0.31
MTOR P42345 1/20 0.31
RAB9A P51151 1/20 0.31
BLM P54132 1/20 0.31
PMP22 Q01453 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18920943 0.81 PPM1B (0.36) MAPK1TP53NFKB1CYP2C19THPO
SCHEMBL22720372 0.80 SCN1A (0.30) SCN1ASCN2ASCN3A
SCHEMBL11647679 0.79 PPM1B (0.33) SCN1ASCN2ASCN3AMAPK1TP53
SCHEMBL2918023 0.77 CYP19A1 (0.30)
SCHEMBL54804 0.76 NAAA (0.31) MAPK1TP53NFKB1CYP2C19THPO
SCHEMBL7936217 0.76
SCHEMBL1547983 0.75 MAPK1 (0.45) MAPK1TP53NFKB1CYP2C19THPO
SCHEMBL27512935 0.75 SMN1; SMN2 (0.33) SMN1; SMN2
SCHEMBL464840 0.75 CYP2C19 (0.36) CYP2C19SMN1; SMN2NPSR1
SCHEMBL17928513 0.74 MAPK1 (0.35) MAPK1TP53NFKB1CYP2C19THPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250257221-A1 PHOTOCURABLE RESIN COMPOSITION CANON KABUSHIKI KAISHA (JP) 2025-08-14 US disclosed
EP-3981858-B1 LIQUID CRYTAL MEDIUM MERCK PATENT GMBH (DE) 2024-04-17 EP disclosed
CN-117120486-A Compound and method for producing same, polymerizable composition, polymer, hologram recording medium, optical material, and optical member 三菱化学株式会社 2023-11-24 CN disclosed
WO-2023085239-A1 METHOD FOR PRODUCING THREE-DIMENSIONAL OBJECT 東レエンジニアリング株式会社 2023-05-19 WO disclosed
US-11548959-B2 Photocurable material composition and cured product thereof CANON KABUSHIKI KAISHA (JP) 2023-01-10 US disclosed
CN-113264856-B Sulfonium salt, photoacid generator, and photosensitive composition 东京应化工业株式会社 2022-11-22 CN disclosed
CN-115279768-A Stereoisomer of epoxy compound, curable composition containing same, and cured product obtained by curing curable composition 引能仕株式会社 2022-11-01 CN disclosed
CN-114746392-A Alicyclic acrylate compound, alicyclic epoxy acrylate compound, curable composition, and cured product 引能仕株式会社 2022-07-12 CN disclosed
CN-114609862-A Photocurable resin sheet 日东电工株式会社 2022-06-10 CN disclosed
EP-3981858-A1 LIQUID CRYTAL MEDIUM Merck Patent GmbH (DE) 2022-04-13 EP disclosed
EP-2502915-B1 AROMATIC SULFONIUM SALT COMPOUND ADEKA CORP (JP) 2015-03-18 EP disclosed
US-8410188-B2 Sealant for one-drop fill process ADEKA CORPORATION (JP) 2013-04-02 US disclosed
EP-2502915-A1 AROMATIC SULFONIUM SALT COMPOUND Adeka Corporation (JP) 2012-09-26 EP disclosed
EP-2495234-A1 AROMATIC SULFONIUM SALT COMPOUND Adeka Corporation (JP) 2012-09-05 EP disclosed
US-8210653-B2 Manufacturing method of print head and print head CANON KABUSHIKI KAISHA (JP) 2012-07-03 US disclosed
US-20120136155-A1 AROMATIC SULFONIUM SALT COMPOUND ADEKA CORPORATION (JP) 2012-05-31 US disclosed
US-20120130117-A1 AROMATIC SULFONIUM SALT COMPOUND ADEKA CORPORATION (JP) 2012-05-24 US disclosed
EP-2455801-A1 SEALING AGENT FOR LIQUID CRYSTAL DRIPPING METHOD Adeka Corporation (JP) 2012-05-23 EP disclosed
US-20110218267-A1 SEALANT FOR ONE-DROP FILL PROCESS ADEKA CORPORATION (JP) 2011-09-08 US disclosed
US-20090315948-A1 MANUFACTURING METHOD OF PRINT HEAD AND PRINT HEAD CANON KABUSHIKI KAISHA (JP) 2009-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120136155-A1 AROMATIC SULFONIUM SALT COMPOUND F12, ASIC1, SPIN1 SCN1A 52/4885SCN2A 276/4885SCN3A 435/4885
US-20120130117-A1 AROMATIC SULFONIUM SALT COMPOUND SLC6A19, ARSA, PAH SCN1A 172/4885SCN2A 325/4885SCN3A 502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.